Pharma Stock Roundup: FDA Approves J&J’s Tremfya for Ulcerative Colitis & More
ZacksFDA approves J&J’s Tremfya for ulcerative colitis. NVO’s oral obesity pill, amycretin, shows faster weight loss than weekly injection, Wegovy.
FDA approves J&J’s Tremfya for ulcerative colitis. NVO’s oral obesity pill, amycretin, shows faster weight loss than weekly injection, Wegovy.